Primary Site >> Colorectal Cancer
Gene >> ICOSLG
|
|
|
|
|---|---|---|---|
|
Ref: Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. PMID: 20140740 |
Ref: Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression. PMID: 25304368 |
Ref: Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade. PMID: 26872462 Ref: Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination. PMID: 27364122 Ref: The clinical impact of ICOS signal in colorectal cancer patients. PMID: 27467961 |
Ref: Expression of B7-H2 on CD8(+) T cells in colorectal cancer microenvironment and its clinical significance. PMID: 29414642 Ref: Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients. PMID: 29505962 Ref: ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy. PMID: 29879883 |